https://www.selleckchem.com/pr....oducts/Decitabine.ht
37). This was further increased for those with clinically meaningful anxiety and depressive symptoms (d=-1.07). This study reports cross-sectional data, and uses a sample enriched with individuals with a family history of dementia who are therefore at a higher risk of developing dementia compared to the general population. Additionally, biological markers such as cortisol, Aβ, and tau were unavailable. The results support the hypothesis that depressive and anxiety symptoms may increase risk of cognitive decline. Further, they suggest
Like
Comment
Share
